LifeStance Health (LFST) Cash from Operations (2020 - 2026)

LifeStance Health has disclosed Cash from Operations across 7 years of filings, most recently posting 33109000.0 for Q1 2026.

• In Q1 2026, Cash from Operations rose 1170.8% year-over-year to 33109000.0; the TTM figure through Mar 2026 stood at 182352000.0 (up 44.72% YoY), while the FY2025 annual figure was 146151000.0, up 36.26% from the prior year.
• Cash from Operations declined to 33109000.0 in Q1 2026, from 57560000.0 in the prior quarter.
• Over the last five years, Cash from Operations for LFST reached as high as 64396000.0 in Q2 2025 and fell as low as 25355000.0 in Q3 2023.
• The 5-year median for Cash from Operations is 16795000.0 (2023), against an average of 18966176.47.
• Annual changes were most pronounced in 2023 — Cash from Operations slumped 542.5% — and 2024, when it jumped 10252.07%.
• A 5-year view of Cash from Operations shows it stood at 35918000.0 in 2022, then plunged by 53.24% to 16795000.0 in 2023, then surged by 271.04% to 62316000.0 in 2024, then slipped by 7.63% to 57560000.0 in 2025, then slumped by 42.48% to 33109000.0 in 2026.
• According to Business Quant data, Cash from Operations over the past three periods registered 33109000.0, 57560000.0, and 27287000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.